Variant report
Variant | esv3369707 |
---|---|
Chromosome Location | chr3:163462558-163466456 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142816990 | chr3:163462620-163462621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554745680 | chr3:163462621-163462622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541655885 | chr3:163462649-163462650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565019004 | chr3:163462707-163462708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2201063 | chr3:163462742-163462743 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs574596776 | chr3:163462836-163462837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543165096 | chr3:163462880-163462881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530632854 | chr3:163462881-163462882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541883720 | chr3:163462890-163462891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7651976 | chr3:163462905-163462906 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs80312761 | chr3:163462907-163462908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577278787 | chr3:163462939-163462940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76320577 | chr3:163462942-163462943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369103499 | chr3:163462968-163462969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528720724 | chr3:163463018-163463019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548355582 | chr3:163463026-163463027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4627755 | chr3:163463086-163463087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1602472 | chr3:163463095-163463096 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs550148354 | chr3:163463111-163463112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531628556 | chr3:163463115-163463116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550302675 | chr3:163463173-163463174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374172612 | chr3:163463174-163463175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139801770 | chr3:163463206-163463207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1602471 | chr3:163463211-163463212 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs149766086 | chr3:163463262-163463263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535560097 | chr3:163463279-163463280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182931120 | chr3:163463289-163463290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs74941526 | chr3:163463328-163463329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545933231 | chr3:163463331-163463332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534849661 | chr3:163463370-163463371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553153116 | chr3:163463379-163463380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547485934 | chr3:163463395-163463396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145733100 | chr3:163463426-163463427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148531483 | chr3:163463459-163463460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565758606 | chr3:163463543-163463544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs2365143 | chr3:163463561-163463562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537161013 | chr3:163463566-163463567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556969074 | chr3:163463567-163463568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs142848749 | chr3:163463590-163463591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs36086248 | chr3:163463594-163463595 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs187954067 | chr3:163463609-163463610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573175907 | chr3:163463632-163463633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542087996 | chr3:163463674-163463675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs114914069 | chr3:163463688-163463689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79173671 | chr3:163463721-163463722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs146577655 | chr3:163463737-163463738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs866942 | chr3:163463759-163463760 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs550799935 | chr3:163463787-163463788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564601553 | chr3:163463790-163463791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163462600-163463800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr3:163462800-163463600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |